What is the price of BillionToOne, Inc. (BLLN)

The price of BillionToOne, Inc. (BLLN) is $99.89

What is the market cap of BillionToOne, Inc. (BLLN)

The market cap of BillionToOne, Inc. (BLLN) is $4.59B

BillionToOne, Inc. (BLLN) Revenue

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Year	Revenue	Change
Not enough data for the provided dates.

Year

Revenue

Change

Not enough data for the provided dates.

Company	Revenue	Revenue Difference	Country
Thermo Fisher Scientific Inc. TMO.US	$46.34B	-	US
Danaher Corporation DHR.US	$25.11B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$2.71B	-	US
Agilent Technologies, Inc. A.US	$7.23B	-	US

Company

Revenue

Revenue Difference

Country